William L. Gluck

Hematology | Oncology

1 Independence Pt Ste 212
Greenville, SC 29615

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Effects of chemotherapy on skeletal muscle mitochondrial oxidative capacity using near-infrared spectroscopy (NIRS): Protocol paper for an observational mixed model repeated measures design in patients with breast and gynecological cancer.

Effects of chemotherapy on skeletal muscle mitochondrial oxidative capacity using near-infrared spectroscopy (NIRS): Protocol paper for an observational mixed model repeated measures design in patients with breast and gynecological cancer.

Journal: PloS one

Published: December 02, 2024

A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.

A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.

Journal: The oncologist

Published: March 05, 2021

Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19.

Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19.

Journal: Respiratory medicine

Published: September 03, 2020

Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma.

Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma.

Journal: Investigational new drugs

Published: June 28, 2019

Showing 1-4 of 4

Last Updated: 09/26/2026